Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.

Pediatr Dermatol

Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Published: April 2008

Nevirapine is a non-nucleoside reverse transcriptase inhibitor commonly used in human immunodeficiency virus-1 multidrug regimens and associated with life-threatening cutaneous reactions. Here, we report the successful use of intravenous immunoglobulin in a pediatric patient with Stevens-Johnson syndrome and highlight the risk of nevirapine usage in human immunodeficiency virus postexposure prophylaxis.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1525-1470.2007.00605.xDOI Listing

Publication Analysis

Top Keywords

stevens-johnson syndrome
8
pediatric patient
8
human immunodeficiency
8
nevirapine-induced stevens-johnson
4
syndrome pediatric
4
patient nevirapine
4
nevirapine non-nucleoside
4
non-nucleoside reverse
4
reverse transcriptase
4
transcriptase inhibitor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!